Sign in

CIK 0001610820 · Non-accelerated filer<br>Smaller reporting company

BriaCell Therapeutics Corp.

Sign in to watch
Ticker
BCTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jul 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 921-1810
Business address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
Former names
Ansell Capital Corp.

Securities

  • BCTX Common Shares Nasdaq
  • BCTXL Warrants Nasdaq
  • BCTXZ Warrant Nasdaq
  1. 8-K Event Regulation FD disclosure
  2. DEF 14A Proxy Proxy Statement
  3. 8-K Event Regulation FD disclosure
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. 4 Open-market buy Chairman bought 28,000 shares at $4.58 ($128,240)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 22,000 shares at $5.35 ($117,700)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Regulation FD disclosure
  10. 8-K Event Regulation FD disclosure
  11. 8-K Event Regulation FD disclosure
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations · Regulation FD disclosure · Other events
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Regulation FD disclosure
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Material agreement
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 9 of 17 · 324 filings